We are live on ! Find out more
MRNX

Defiance Daily Target 2X Long MRNA ETF
MRNX

2 hedge funds and large institutions have $97.9K invested in Defiance Daily Target 2X Long MRNA ETF in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2.55% more ownership

Funds ownership: 0% → 2.55% (+2.6%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Optiver Holding
Optiver Holding
Netherlands
+$55K
2
MCA
McGuire Capital Advisors
Oklahoma
+$4.12K

Top Sellers

No sellers this quarter

MRNX Hedge Fund Activity: Q2 2026 in Review

2 of the 8,287 institutional investors tracked by Wall St. Rank reported a position in Defiance Daily Target 2X Long MRNA ETF (MRNX) for Q2 2026, worth a combined $97.9K.

Buyers outnumbered sellers: 2 funds opened new MRNX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Optiver Holding, opening a new position worth an estimated $55K.

  • 2 institutional investors held Defiance Daily Target 2X Long MRNA ETF (MRNX) as of Q2 2026, up from 0 in Q1 2026.
  • Funds reported $97.9K of Defiance Daily Target 2X Long MRNA ETF stock for Q2 2026.
  • 2 funds opened new Defiance Daily Target 2X Long MRNA ETF positions in Q2 2026 and 0 closed out, a net change of +2 holders.
  • The largest Defiance Daily Target 2X Long MRNA ETF buyer in Q2 2026 was Optiver Holding, an estimated $55K added.

Based on aggregated 13F filings for Q2 2026.